| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/03/2008 | CN101255441A AFP recombinant gland related viral vectors as well as construction method and uses thereof |
| 09/03/2008 | CN101255439A Bird infectious bronchitis virus N-gene and bird IL-2 gene co-expressing DNA bacterin pIRES-N/IL2 |
| 09/03/2008 | CN101255434A Vaccines |
| 09/03/2008 | CN101255422A siRNA sequence suppressing expression of bax gene |
| 09/03/2008 | CN101255418A Human heparinase RNA interference target sequence and uses thereof |
| 09/03/2008 | CN101254310A Applications human neuro nutriment-3 receptor gene recombination ad virus for preparing medicine treating nerve injury |
| 09/03/2008 | CN101254233A Gene therapy for radical curing SARS respiratory disease |
| 09/03/2008 | CN101254171A Spray containing small molecule disturbance ribonucleic acid |
| 09/03/2008 | CN100415299C Correlation factor of blastocyst nidation and application |
| 09/03/2008 | CN100415298C Adenovirus vector for idiopathy liver genetherapy and using method |
| 09/03/2008 | CN100415296C Compositions containing inclusion complexes |
| 09/02/2008 | US7420100 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy |
| 09/02/2008 | US7420050 TGF-β-specific covalently closed antisense molecule |
| 09/02/2008 | US7420045 IAPs associated cell cycle proteins, compositions and methods of use |
| 09/02/2008 | US7420030 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 09/02/2008 | US7419964 Treatment of HSV-related pathologies using ssDNA |
| 09/02/2008 | US7419955 Especially from intimal thickening, by administering a C-terminal globular domain of adiponectin to down-regulate expression of scavenger receptor A |
| 09/02/2008 | US7419948 Recombinant human Factor IX produced by a transgenic pig having an exogenous DNA stably integrated into its genome that secretes the biologically active Factor into its milk; the factor may be gamma -carboxylated |
| 09/02/2008 | US7419829 Mutated woodchuck posttranscriptional regulatory element (WPRE) sequence having ablated X protein tumorigenic activity; safely used in retroviral and lentiviral vectors to enhance expression levels of heterologous genes or nucleotides |
| 09/02/2008 | US7419828 Compositions and methods for non-targeted activation of endogenous genes |
| 09/02/2008 | US7419827 Neural stem cell culture for prevention and treatment of brain and nervous sytem disorders |
| 09/02/2008 | US7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 09/02/2008 | US7419816 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 09/02/2008 | US7419807 High molecular weight; isolated nucleic acid; use in detecting antibodies in test sample; diagnostic kit |
| 09/02/2008 | US7419804 CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS |
| 09/02/2008 | US7419659 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 09/02/2008 | CA2271244C Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/02/2008 | CA2108927C Wilson disease gene |
| 08/28/2008 | WO2008103993A2 Compositions and methods for treating glycogen storage diseases |
| 08/28/2008 | WO2008103763A2 Methods and compositions for cancer diagnosis and treatment based on nucleic acid methylation |
| 08/28/2008 | WO2008103755A1 Treating cancer with viral nucleic acid |
| 08/28/2008 | WO2008103380A2 Hepatitis b virus compositions and methods of use |
| 08/28/2008 | WO2008103276A2 Compositions and methods for potentiated activity of biologicaly active molecules |
| 08/28/2008 | WO2008103135A2 The micrornaome |
| 08/28/2008 | WO2008102912A1 Target protein and target gene for drug discovery, and screening method |
| 08/28/2008 | WO2008102783A1 Hair regrowth promoter |
| 08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | WO2008102199A1 Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof |
| 08/28/2008 | WO2008101354A1 Gpr65 as a therapeutic target in allergic airway inflammation |
| 08/28/2008 | WO2008101349A1 Recombinant viral vectors for prevention and protection against alphavirus infection |
| 08/28/2008 | WO2008010093A3 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 08/28/2008 | WO2006128025A3 Regulatory proteins in lung repair and treatment of lung disease |
| 08/28/2008 | US20080209581 Induction of exon skipping in eukaryotic cells |
| 08/28/2008 | US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 08/28/2008 | US20080207552 Decoy compositions for treating and preventing brain diseases and disorders |
| 08/28/2008 | US20080207543 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 08/28/2008 | US20080207539 Self-Processing Rna Expression Cassette |
| 08/28/2008 | US20080207520 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080207506 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents |
| 08/28/2008 | US20080207489 Use of CCN5 for treatment of smooth muscle proliferation disorders |
| 08/28/2008 | US20080206873 Recombinant pre-integration complex (rPIC) for use as gene transfer tool in genetic engineering |
| 08/28/2008 | US20080206837 Stable adenoviral vectors and methods for propagation thereof |
| 08/28/2008 | US20080206835 Methods and Compositions Relating to Gene Silencing |
| 08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
| 08/28/2008 | US20080206750 Novel fetal genes |
| 08/28/2008 | US20080206341 Lipid Nanoparticles as Vehicles for Nucleic Acids, Process for Their Preparation and Use |
| 08/28/2008 | US20080206298 Enhanced biological autologous tissue adhesive composition and methods of preparation and use |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 08/28/2008 | US20080206265 Using oligonucleotide immunostimulant mixture with drug; Modification of an immunostimulatory oligonucleotide to optimally present 5' ends dramatically enhances its anti-cancer activity |
| 08/28/2008 | US20080206256 Treatments for cancer |
| 08/28/2008 | US20080206255 Antibody cancer immunotherapy |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 08/28/2008 | US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206219 Using cytokine modulators as therapeutic tools in treatment of vascular permeability disorders |
| 08/28/2008 | US20080206210 gene therapy by intrathymic administration; lentiviral vectors |
| 08/28/2008 | US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine |
| 08/28/2008 | US20080206202 Propagating nervous system tissues from stem cell tissue in mixture comprising dimethylsulfoxide; treating muscular disorders; tissue engineering; regenerative medicine |
| 08/28/2008 | US20080206198 Using epithelial sodium channel (ENaC) inhibitor to treat and prevent nervous system and lung disorders |
| 08/28/2008 | US20080206197 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 08/28/2008 | US20080206195 Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism |
| 08/28/2008 | US20080206194 Inducing estrogen receptor-alpha expression by administering peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist |
| 08/28/2008 | CA2680063A1 Compositions and methods for treating glycogen storage diseases |
| 08/28/2008 | CA2678757A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | CA2678709A1 Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof |
| 08/28/2008 | CA2678409A1 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides |
| 08/27/2008 | EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer |
| 08/27/2008 | EP1961818A2 Novel fetal genes |
| 08/27/2008 | EP1961816A1 Novel highly functional enzyme having modified substrate-specificity |
| 08/27/2008 | EP1961813A2 Human cyclin-dependent kinase (hPNQALRE) |
| 08/27/2008 | EP1961428A1 SC6 antibody for treatment of cancer |
| 08/27/2008 | EP1960426A1 Novel neurotrophic factor protein and uses thereof |
| 08/27/2008 | EP1959979A1 Methods for promoting neurite outgrowth and survival of dopaminergic neurons |
| 08/27/2008 | EP1959969A2 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 08/27/2008 | EP1446504B1 Emulsion compositions |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1234025B1 Human enzymes of the metalloprotease family |
| 08/27/2008 | EP1028754B1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
| 08/27/2008 | EP1007555B1 Tropoelastin derivatives |
| 08/27/2008 | EP0931157B1 Retroviral vectors |
| 08/27/2008 | EP0827410B1 Method for introducing and expressing genes in animal cells |
| 08/27/2008 | CN101252953A Electrotransfer of nucleic acid into tissue cells |
| 08/27/2008 | CN101250529A Horse infectious anemia virus soluble acceptor, coded sequence and uses thereof |
| 08/27/2008 | CN101250219A Short peptide series suppressing growth of leukemia cancer cell and uses thereof |
| 08/27/2008 | CN101249267A Application of soluble transform growth factor-beta receptor gene for curing skin scar |
| 08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
| 08/27/2008 | CN100413540C Gene carrying rack and its producing method and use |